Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Saunders

Showing results (241-250 of 276) with videos related to

Pageof 28
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 14, 2019
Detection in the United Kingdom of the <i>Neisseria gonorrhoeae</i> FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018David W Eyre, Katy Town, Teresa Street, et al.
Journal of Medicinal Chemistry|February 18, 2005
3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterizationFabio C Tucci, Yun-Fei Zhu, R Scott Struthers, et al.
Bioorganic & Medicinal Chemistry|April 18, 2008
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonistsChen Chen, Fabio C Tucci, Wanlong Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2007
Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonistsMi Chen, Zhiqiang Guo, Marion C Lanier, et al.
Alimentary Pharmacology & Therapeutics|October 10, 2019
Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patientsChristian P Selinger, Gareth C Parkes, Ash Bassi, et al.
Journal of Medicinal Chemistry|June 25, 2004
3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptorFabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Journal of Medicinal Chemistry|November 13, 2007
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptorJoe A Tran, Wanlong Jiang, Fabio C Tucci, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivativesMinoru Imai, Tatsuki Shiota, Ken-ichiro Kataoka, et al.
BMC Biology|October 31, 2009
Genetical genomic determinants of alcohol consumption in rats and humansBoris Tabakoff, Laura Saba, Morton Printz, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.
Pageof 28

Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 14, 2019
Detection in the United Kingdom of the <i>Neisseria gonorrhoeae</i> FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018David W Eyre, Katy Town, Teresa Street, et al.
Journal of Medicinal Chemistry|February 18, 2005
3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterizationFabio C Tucci, Yun-Fei Zhu, R Scott Struthers, et al.
Bioorganic & Medicinal Chemistry|April 18, 2008
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonistsChen Chen, Fabio C Tucci, Wanlong Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2007
Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonistsMi Chen, Zhiqiang Guo, Marion C Lanier, et al.
Alimentary Pharmacology & Therapeutics|October 10, 2019
Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patientsChristian P Selinger, Gareth C Parkes, Ash Bassi, et al.
Journal of Medicinal Chemistry|June 25, 2004
3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptorFabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Journal of Medicinal Chemistry|November 13, 2007
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptorJoe A Tran, Wanlong Jiang, Fabio C Tucci, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivativesMinoru Imai, Tatsuki Shiota, Ken-ichiro Kataoka, et al.
BMC Biology|October 31, 2009
Genetical genomic determinants of alcohol consumption in rats and humansBoris Tabakoff, Laura Saba, Morton Printz, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.
Pageof 28